{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=227938", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?uin=227938", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=227938&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&uin=227938", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=227938", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=227938", "items" : [{"_about" : "http://data.parliament.uk/resources/1081733", "AnsweringBody" : [{"_value" : "Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1081733/answer", "answerText" : {"_value" : "

UK traders that only trade with the EU will need an EORI number in the event the UK leaves the EU without a deal. HMRC estimated that in 2017 there were 144,000 VAT-registered traders that only traded with the EU. A separate estimate indicates there are approximately 100,000 non VAT-registered traders that trade only with the EU. The latest HMRC validated data shows that in the three months to 1 March 2019, which covers the period from the start of the business readiness campaign, there were 53,098 registrations for an EORI number, and numbers are growing each week.<\/p>

<\/p>

As HMRC only holds information on UK-EU traders that are VAT-registered, a large population of traders would not automatically receive an EORI number if they were automatically generated. Providing numbers for some traders that needed it, but not all, would send mixed messages about whether it was required. Furthermore, the VAT registration details for a trader can be different from the trading entity that needs an EORI number, meaning automated registration could result in registering the wrong entity.<\/p>

<\/p>

The Government has focused on ensuring the process of applying for an EORI is free and very quick, it currently takes around 10 minutes. The Government has also recently announced temporary simplified procedures to make importing and exporting easier. To register for these simplifications, traders will need a UK EORI number. Therefore, completing the application is a good first step for traders.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3935", "label" : {"_value" : "Biography information for Mel Stride"} } , "answeringMemberConstituency" : {"_value" : "Central Devon"} , "answeringMemberPrinted" : {"_value" : "Mel Stride"} , "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "227939"} , {"_value" : "227940"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-03-12T08:31:24.7Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "Treasury"} , "date" : {"_value" : "2019-03-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "UK Trade with EU"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Chancellor of the Exchequer, for what reason EORI numbers cannot be automatically allocated to intra-EU only traders with registered VAT numbers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/320", "label" : {"_value" : "Biography information for Mr Adrian Bailey"} } , "tablingMemberConstituency" : {"_value" : "West Bromwich West"} , "tablingMemberPrinted" : [{"_value" : "Mr Adrian Bailey"} ], "uin" : "227938"} , {"_about" : "http://data.parliament.uk/resources/227869", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/227869/answer", "answerText" : {"_value" : "

NHS England has advised that cabazutaxel (Jevtana) was removed from the national Cancer Drugs Fund (CDF) list on 12 March 2015 as the CDF clinical panel concluded that the clinical benefits of cabazitaxel in patients with metastatic castrate-resistant prostate cancer, who had received prior treatment with docetaxel, were insufficient for it to merit retention on the national list. The full decision summary is available at:<\/p>

<\/p>

<\/p>

<\/p>

www.england.nhs.uk/wp-content/uploads/2015/01/ncdf-summ-cabaztxl-post-doctxl.pdf<\/a><\/p>

<\/p>

<\/p>

<\/p>

Patients currently receiving cabazitaxel through the Fund will remain on that treatment until such a time when they are no longer receiving benefit from the treatment. Clinicians will still be able to apply for individual patients to receive cabazitaxel on an exceptional basis.<\/p>

<\/p>

<\/p>

<\/p>

NHS England follows a standard operating procedure when responding to individual requests to fund cancer treatments. This requires a response to the request within 10 working days following a receipt of a complete submission from the clinician. Further details are available at:<\/p>

<\/p>

<\/p>

<\/p>

www.england.nhs.uk/ourwork/pe/cdf/<\/a><\/p>

<\/p>

<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4020", "label" : {"_value" : "Biography information for George Freeman"} } , "answeringMemberConstituency" : {"_value" : "Mid Norfolk"} , "answeringMemberPrinted" : {"_value" : "George Freeman"} , "dateOfAnswer" : {"_value" : "2015-03-24", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-03-24T16:27:28.62Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-03-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Prostate Cancer: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment he has made of the impact on prostate cancer patients of the delisting of the drug cabazitaxel by the Cancer Drugs Fund; what steps NHS England plans to take to maintain access to cabazitaxel for prostate cancer patients until it has been subject to review by NICE; and what assessment he has made of the effectiveness of the Individual Funding Request process for cancer drugs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1568", "label" : {"_value" : "Biography information for Mrs Anne Main"} } , "tablingMemberConstituency" : {"_value" : "St Albans"} , "tablingMemberPrinted" : [{"_value" : "Mrs Anne Main"} ], "uin" : "227938"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }